These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6858602)

  • 1. Mechanisms of development of prolactin-induced adenomyosis in mice.
    Mori T; Nagasawa H
    Acta Anat (Basel); 1983; 116(1):46-54. PubMed ID: 6858602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis.
    Mori T; Ohta Y; Nagasawa H
    Experientia; 1984 Dec; 40(12):1385-7. PubMed ID: 6510494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain-difference in the induction of adenomyosis by intrauterine pituitary grafting in mice.
    Mori T; Nagasawa H; Nakajima Y
    Lab Anim Sci; 1982 Feb; 32(1):40-1. PubMed ID: 7078070
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal model of uterine adenomyosis: induction of the lesion in rats by ectopic pituitary isografting.
    Mori T; Kyokuwa M; Nagasawa H
    Lab Anim Sci; 1998 Feb; 48(1):64-8. PubMed ID: 9517893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in gonadotropin, prolactin and growth hormone levels with reference to the development of uterine adenomyosis in female SHN mice.
    Singtripop T; Mori T; Shiraishi K; Park MK; Kawashima S
    In Vivo; 1993; 7(2):147-50. PubMed ID: 8364165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the development of mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN mice by different schedules of treatment with CB-154.
    Mori T; Nagasawa H
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):245-9. PubMed ID: 6495991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of adenomyosis in mice by intrauterine pituitary isografts.
    Mori T; Nagasawa H; Takahashi S
    Life Sci; 1981 Sep; 29(12):1277-82. PubMed ID: 7300555
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in citrate concentration in the mouse uterus with experimentally-induced adenomyosis.
    Iizuka A; Nakabachi A; Mori T; Park MK; Fujii Y; Nagasawa H
    Life Sci; 1996; 58(5):397-403. PubMed ID: 8594304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of DNA synthesis in uterine adenomyosis in mice with ectopic pituitary isograft.
    Sakamoto S; Mori T; Singtripop T; Kawashima S; Suzuki S; Kudo H; Sawaki K; Nagasawa H
    Acta Anat (Basel); 1992; 145(2):162-6. PubMed ID: 1441889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol, a hypocholesterolemic agent, prevents the development of uterine adenomyosis induced by pituitary grafting in mice.
    Zhou YF; Mori T; Nagasawa H; Nakayama T; Kubota T; Sakamoto S
    Anticancer Res; 2004; 24(4):2209-12. PubMed ID: 15330162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the development of uterine adenomyosis by danazol treatment in mice.
    Singtripop T; Mori T; Sakamoto S; Sassa S; Park MK; Kawashima S
    Life Sci; 1992; 51(14):1119-25. PubMed ID: 1518375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment with prolactin or progesterone on the coincidence of mammary tumors and uterine adenomyosis in young SHN mice.
    Nagasawa H; Ishida M; Mori T
    Lab Anim Sci; 1987 Apr; 37(2):200-2. PubMed ID: 2885443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological analysis of spontaneous adenomyosis-like changes in recombinant inbred mouse uterus (SMXA mouse)--a novel animal model for adenomyosis].
    Kida H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Apr; 46(4):323-30. PubMed ID: 8151174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin role in the bovine uterus during adenomyosis.
    Łupicka M; Socha BM; Szczepańska AA; Korzekwa AJ
    Domest Anim Endocrinol; 2017 Jan; 58():1-13. PubMed ID: 27591979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice.
    Zhou YF; Matsuda M; Mori T; Sakamoto S; Mitamura T
    Life Sci; 2000 Oct; 67(22):2713-20. PubMed ID: 11105987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice.
    Mori T; Yamasaki S; Masui F; Matsuda M; Sasabe H; Zhou YF
    Exp Biol Med (Maywood); 2001 May; 226(5):429-33. PubMed ID: 11393170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced potentials for mammary tumourigenesis and uterine adenomyosis in (SLN x C3H/He)F1 virgin mice.
    Nagasawa H; Naito T
    Lab Anim; 1992 Jan; 26(1):23-4. PubMed ID: 1548842
    [No Abstract]   [Full Text] [Related]  

  • 18. Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus.
    Mori T; Kurata Y; Tabata Y; Niho N; Matsuda M; Zhou YF
    Life Sci; 2002 Jun; 71(5):527-35. PubMed ID: 12052437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice?
    Mori T; Singtripop T; Kawashima S
    Am J Obstet Gynecol; 1991 Jul; 165(1):232-4. PubMed ID: 1853904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in the number of integrinbeta1-immunoreactive monocyte-lineage cells in experimentally-induced adenomyosis in mice.
    Kawahara R; Matsuda M; Mori T
    Life Sci; 2003 Jul; 73(7):907-16. PubMed ID: 12798416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.